Open Access<p>Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma</p>
Author(s) -
Shorook Na’ara,
Angshuman Mukherjee,
Salem Billan,
Ziv Gil
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s182580
Subject(s) - medicine , mucosal melanoma , nasal cavity , melanoma , radiation therapy , adjuvant , adverse effect , maxillary sinus , multidisciplinary team , immunotherapy , sinus (botany) , multidisciplinary approach , oncology , surgery , dermatology , cancer , cancer research , social science , botany , nursing , sociology , biology , genus
Sinonasal mucosal melanoma (SNMM) is a rare tumor, comprising less than 10% of sinonasal malignancies. SNMM most frequently occurs in the nasal cavity (70%) and maxillary sinus (14%), typically as black patches. Overall, SNMM harbors a very poor prognosis; 5-year survival is less than 30%. Nasal cavity tumors confer a better prognosis than sinus melanoma. The primary management for SNMM is surgery, when feasible, followed by adjuvant radiotherapy. Recent studies suggest that immunotherapy may confer survival benefit to patients with advanced disease. The multidisciplinary team approach has been shown to optimize treatment, reduce costs, and minimize adverse events, while maximizing the chances for cure.